Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Prothena Corporation plc - Ordinary Shares
(NQ:
PRTA
)
8.720
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prothena Corporation plc - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 30, 2024
Via
Benzinga
Crude Oil Moves Higher; Prime Medicine Shares Spike Higher
↗
September 30, 2024
Via
Benzinga
Prothena Announces Leadership Team Updates
September 27, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Participate in Upcoming Healthcare Conferences
August 29, 2024
From
Prothena Corporation plc
Via
Business Wire
Demystifying Prothena Corp: Insights From 8 Analyst Reviews
↗
March 13, 2024
Via
Benzinga
Decoding 6 Analyst Evaluations For Prothena Corp
↗
February 16, 2024
Via
Benzinga
PRTA Stock Earnings: Prothena Corp Beats EPS, Beats Revenue for Q2 2024
↗
August 08, 2024
PRTA stock results show that Prothena Corp beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Prothena Reports Second Quarter 2024 Financial Results and Business Highlights
August 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report Second Quarter 2024 Financial Results on August 8
August 01, 2024
From
Prothena Corporation plc
Via
Business Wire
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
↗
June 11, 2024
An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday.
Via
Investor's Business Daily
Prothena Corp: Q4 Earnings Insights
↗
February 15, 2024
Via
Benzinga
Earnings Scheduled For February 15, 2024
↗
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via
Benzinga
Earnings Outlook For Prothena Corp
↗
February 14, 2024
Via
Benzinga
Navigating 5 Analyst Ratings For Prothena Corp
↗
January 25, 2024
Via
Benzinga
Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
May 28, 2024
From
Prothena Corporation plc
Via
Business Wire
PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024
↗
May 08, 2024
PRTA stock results show that Prothena Corp missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Prothena Reports First Quarter 2024 Financial Results and Business Highlights
May 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report First Quarter 2024 Financial Results on May 8
May 01, 2024
From
Prothena Corporation plc
Via
Business Wire
$100 Invested In Prothena Corp 5 Years Ago Would Be Worth This Much Today
↗
January 22, 2024
Via
Benzinga
Demystifying Prothena Corp: Insights From 5 Analyst Reviews
↗
January 09, 2024
Via
Benzinga
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
April 15, 2024
From
Prothena Corporation plc
Via
Business Wire
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
↗
March 28, 2024
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.
Via
Investor's Business Daily
Prothena to Participate in Upcoming Healthcare Conferences
March 05, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena Appoints David Ford to Newly Created Chief People Officer Position
March 04, 2024
From
Prothena Corporation plc
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
↗
February 29, 2024
Via
Benzinga
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
February 21, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
February 15, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
February 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
January 30, 2024
Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales
Via
Benzinga
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
January 09, 2024
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market...
Via
Benzinga
Topics
Stocks
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
